You have 9 free searches left this month | for more free features.

Risk Adapted Therapy

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • Induction Chemotherapy
  • +3 more
  • Palo Alto, California
  • +5 more
Nov 29, 2022

Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,

Completed
  • Non-Hodgkin's Lymphoma
  • Etoposide, carboplatin, ifosfamide
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 23, 2022

Hodgkin Lymphoma Trial in Valhalla (Brentuximab Vedotin, Doxorubicin, Vincristine)

Active, not recruiting
  • Hodgkin Lymphoma
  • Brentuximab Vedotin
  • +3 more
  • Valhalla, New York
    New York Medical College
Sep 27, 2022

Suicide, Depression, Caregiver Burden Trial (Adapted Dialectical Behavior Therapy)

Not yet recruiting
  • Suicide
  • +4 more
  • Adapted Dialectical Behavior Therapy
  • (no location specified)
Sep 19, 2023

HPV-Associated Oropharyngeal Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Mediated

Recruiting
  • HPV-Associated Oropharyngeal Squamous Cell Carcinoma
  • +11 more
  • NavDx HPV ctDNA Testing
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jul 6, 2022

Prostate Cancer Trial in Miami (FTLEAD, Ultra-Short-Term Androgen Deprivation Therapy with Relugolix, HypoLEAD)

Not yet recruiting
  • Prostate Cancer
  • FTLEAD
  • +3 more
  • Miami, Florida
    University of Miami
Oct 26, 2023

Suicide Risk Trial in Islamabad (Young Adults Culturally Adapted Manual Assisted Psychological Therapy (YA-CMAP), Min Plan Tool)

Recruiting
  • Suicide Risk
  • Young Adults Culturally Adapted Manual Assisted Psychological Therapy (YA-CMAP)
  • Min Plan Tool
  • Islamabad, Capital, Pakistan
    International Islamic University
Jul 4, 2022

AIDS-Related Anal Carcinoma, Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma Trial in United States (drug, radiation,

Recruiting
  • AIDS-Related Anal Carcinoma
  • +22 more
  • San Francisco, California
  • +8 more
Jan 27, 2023

Newly Diagnosed Multiple Myeloma Trial in Germany (Isatuximab, Lenalidomide, Bortezomib)

Not yet recruiting
  • Newly Diagnosed Multiple Myeloma
  • Hamburg, Germany
  • +3 more
Dec 16, 2022

Leukemia, Myeloid, Acute Trial in Spain (Idarubicin, Ara-C, G-CSF)

Recruiting
  • Leukemia, Myeloid, Acute
  • Badalona, Barcelona, Spain
  • +14 more
Jul 30, 2021

Mantle Cell Lymphoma, Non-hodgkin Lymphoma, Non Hodgkin Lymphoma Trial in Madison (Bendamustine, Obinutuzumab)

Recruiting
  • Mantle Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 13, 2022

Head Neck Cancer Trial in Boston (Radiation therapy)

Recruiting
  • Head and Neck Cancer
  • Radiation therapy
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Feb 14, 2022

Tobacco-Related Carcinoma Trial in United States (Best Practice, Survey Administration, Tobacco Cessation Counseling)

Recruiting
  • Tobacco-Related Carcinoma
  • Best Practice
  • +3 more
  • Lexington, Kentucky
  • +3 more
Apr 23, 2022

Multiple Myeloma Trial in Tampa (Lenalidomide, Prednisone, Dexamethasone)

Completed
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Oct 8, 2021

Medulloblastoma Trial in Zürich (Sonidegib, Cisplatin, Lomustine)

Not yet recruiting
  • Medulloblastoma
  • Zürich, Switzerland
    University Hospital zurich
May 20, 2020

Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

Completed
  • Acute Promyelocytic Leukemia
  • Tretinoin and Arsenic Trioxide
  • Los Angeles, California
  • +11 more
Nov 2, 2021

Acute Lymphoblastic Leukemia, Pediatric, ALL, Infants Trial (the risk-adapted choice of therapy and the use of a combination of

Not yet recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • ALL, Infants
  • the risk-adapted choice of therapy and the use of a combination of chemotherapy with immunotherapy and hematopoietic stem cell transplantation for patients with risk factors.
  • (no location specified)
Aug 26, 2021

Suicidal Ideation Trial in Rawalpindi (ECMAP)

Not yet recruiting
  • Suicidal Ideation
  • ECMAP
  • Rawalpindi, Punjab, Pakistan
    Benazir Bhutto Hospital
Aug 25, 2023

Allogeneic Hematopoietic Stem Cell Transplantation, Allogeneic Stem Cell Transplantation, Hematologic Malignancies Trial in

Not yet recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +2 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Aug 31, 2023

ISS Stage III Plasma Cell Myeloma, Plasma Cell Myeloma Trial in Rochester (procedure, drug, biological)

Not yet recruiting
  • ISS Stage III Plasma Cell Myeloma
  • Plasma Cell Myeloma
  • Bone Marrow Aspiration and Biopsy
  • +7 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 9, 2022

dapted Strategy Including Magnetic Resonance Imaging and

Completed
  • Prostate Cancer
  • Prostate Adenocarcinoma
    • Ankara, Turkey
      Ankara University School of Medicine
    Sep 6, 2023

    Anorexia Nervosa, Exercise Therapy, Videoconferencing Trial in Caen (Adapted Physical Activity (APA))

    Active, not recruiting
    • Anorexia Nervosa
    • +2 more
    • Adapted Physical Activity (APA)
    • Caen, Calvados, France
      Caen University Hospital
    Mar 3, 2023

    Internet Gaming Disorder Trial in Islamabad (Indigenously Adapted Cognitive Behavioral Therapy)

    Recruiting
    • Internet Gaming Disorder
    • Indigenously Adapted Cognitive Behavioral Therapy
    • Islamabad, Federal Capital Area, Pakistan
      Bahria University
    Jun 23, 2023

    Diffuse Large B Cell Lymphoma (DLBCL) Trial in Toronto (glofitamab)

    Not yet recruiting
    • Diffuse Large B Cell Lymphoma (DLBCL)
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Sep 18, 2023

    Lymphoma Trial (Ultra Low Dose 4 Gy Radiation)

    Not yet recruiting
    • Lymphoma
    • Ultra Low Dose 4 Gy Radiation
    • (no location specified)
    Jun 30, 2023